Numerous clinical studies have proposed that a low level of apolipoprotein E (APOE) genotype [51,52,53] along with its genetic variations [54,55] increases the risk of dementia; especially for individuals where dementia has been diagnosed in first-degree relatives (see Table 2). The gene discussed is APOE; the disease is dementia.